One-year results on the safety and efficacy of the InnFocus MicroShunt depending on placement and concentration of mitomycin C [Résultats à un an de l’efficacité et de l’innocuité du MicroShunt InnFocus selon l’emplacement et la concentration de MMC]

Riss I., Batlle J., Pinchuk L., Kato Y.P., Weber B.A., Parel J.-M.

2015
Journal Francais d'Ophtalmologie

View publication

Therapeutic Area

Glaucoma
Categories

Clinical development

Affiliations

Pôle Ophtalmologique, Clinique Mutualiste, 46/54, avenue du Dr-Albert-Schweitzer, Pessac, 33600, France; Centro Laser, Santo Domingo, Calle Padre Fantino Falco 3, Santo Domingo, Dominica; InnFocus Inc., 12415 SW 136th Avenue #3, Miami, FL 33186, United States; Ophthalmic Biophysics Center, Bascom Palmer Eye Institute, University of Miami Miller, 900 NW 17th Street, Miami, FL 33136, United States

Related Publications

Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial

Wang T.H.; Aung T.; Lu D.-W.; George R.; Senthil S.; Lu F.; Odani-Kawabata N.; Park K.H.

Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study.

Bacharach, Jason; McLaurin, Eugene B.; Silverstein, Steven; Amrane, Mourad; Garrigue, Jean-Sebastien; Ismail, Dahlia; Flynn, William J.; Catiolanze Phase 2 study group

Assessment of Brain-Derived Neurotrophic Factor on Retinal Structure and Visual Function in Rodent Models of Optic Nerve Crush

Taniguchi T.; Sharif N.A.; Ota T.; Farjo R.A.; Rausch R.

View all Glaucoma publications